Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by rjc7on Oct 16, 2020 5:20pm

117 Views

Post# 31732714

RE:Why?

Frustrating for sure. I think MBX has a lot of unsophisticated investors. They try to day-trade the stock. They are really not "investors". Short term traders trying to make a few hundred bucks over the course of the day not really caring about the overall price of the stock. Until we get consistant high volume trading days north of $1.00/share things won't change much. jmho

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles